Form 8-K - Current report:
SEC Accession No. 0001104659-22-052847
Filing Date
2022-04-29
Accepted
2022-04-29 08:00:46
Documents
12
Period of Report
2022-04-26
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2213933d1_8k.htm   iXBRL 8-K 24352
  Complete submission text file 0001104659-22-052847.txt   195399

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bpmc-20220426.xsd EX-101.SCH 3063
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE bpmc-20220426_lab.xml EX-101.LAB 34476
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bpmc-20220426_pre.xml EX-101.PRE 22615
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2213933d1_8k_htm.xml XML 3495
Mailing Address 45 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 45 SIDNEY STREET CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Filer) CIK: 0001597264 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37359 | Film No.: 22870281
SIC: 2834 Pharmaceutical Preparations